Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines
Janssen adenovirus type 26 vectored vaccine may be considered for individuals who self-report PEG allergy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.